Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma

Published:2023-11 Issue:11 Volume:41 Page:1852-1870.e9
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Liu Zhichao,Zhang Yaru,Ma Ning,Yang Yang,Ma Yunlong,Wang Feng,Wang Yan,Wei Jinzhi,Chen Hongyan,Tartarone Alfredo,Velotta Jeffrey B.,Dayyani Farshid,Gabriel Emmanuel,Wakefield Connor J.,Kidane Biniam,Carbonelli Cristiano,Long Lingyun,Liu Zhihua,Su Jianzhong,Li Zhigang^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference111 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA A Cancer J. Clin.,2021

2. Epidemiology of Esophageal Squamous Cell Carcinoma;Abnet;Gastroenterology,2018

3. Comprehensive registry of esophageal cancer in Japan;Watanabe;Esophagus,2022

4. Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China;He;Cancer Commun.,2020

5. Neoadjuvant Chemoradiotherapy Using Cisplatin and 5-Fluorouracil (PF) Versus Carboplatin and Paclitaxel (CROSS Regimen) for Esophageal Squamous Cell Carcinoma (ESCC): A Propensity Score-matched Study;Wong;Ann. Surg.,2020

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of radiotherapy and PD-L1 blockade induces abscopal responses in EGFR-mutated lung cancer through activating CD8+ T cells;Translational Oncology;2024-10

2. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09

3. Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells;Cancer Cell;2024-09

4. Blood immunomap for prediction of responses to aPD1 immunotherapy in metastatic non-small cell lung cancer;2024-08-28

5. Preoperative MRI features for predicting response to postoperative adjuvant anti-PD-1 therapy in hepatocellular carcinoma;2024-08-11